Provided by Tiger Trade Technology Pte. Ltd.

Editas Medicine

2.52
-0.0500-1.95%
Post-market: 2.570.0500+1.98%19:30 EDT
Volume:1.54M
Turnover:3.96M
Market Cap:385.56M
PE:-3.45
High:2.62
Open:2.61
Low:2.52
Close:2.57
52wk High:4.54
52wk Low:1.66
Shares:153.00M
Float Shares:115.00M
Volume Ratio:0.70
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7307
EPS(LYR):-1.8036
ROE:-118.82%
ROA:-23.29%
PB:3.66
PE(LYR):-1.40

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Disc Medicine (IRON)

TIPRANKS
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)

TIPRANKS
·
Aug 06

Editas Medicine Q2 2026 earnings: Deferred revenue and restructuring narrow the loss

TradingKey
·
Aug 06

Editas Medicine Strengthens Board With New Cardiology Director

TIPRANKS
·
Aug 06

Editas Medicine Q2 EPS $(0.15) Beats $(0.27) Estimate, Sales $11.900M Beat $2.800M Estimate

Benzinga Earnings
·
Aug 06

Editas Medicine Q2 Net Loss Narrows and Beats Estimates

Reuters
·
Aug 06

Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million

Reuters
·
Aug 06

Editas Medicine Announces Second Quarter 2026 Results and Business Updates

THOMSON REUTERS
·
Aug 06

Editas Medicine Q2 Basic EPS USD -0.15

THOMSON REUTERS
·
Aug 06

Editas Medicine Names Patrick Ellinor to Board, Elliott Levy to Step Down

Reuters
·
Aug 05

Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.d., Ph.d.

THOMSON REUTERS
·
Aug 05

Genflow Appoints Gad Berdugo as Independent Non-executive Chairman

Reuters
·
Jul 13

Editas Medicine Shareholders Back Board, Pay and Auditor

TIPRANKS
·
Jun 19

Editas Medicine shareholders elect Connaughton, Levy as Class I directors at annual meeting

Reuters
·
Jun 19

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

GlobeNewswire
·
May 29

Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI

TIPRANKS
·
May 28

TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’

TIPRANKS
·
May 28

BUZZ-Editas Medicine down after $125 mln stock-and-warrants offering

Reuters
·
May 26

Editas Medicine Announces Pricing of up to $319.4 Million Public Offering

THOMSON REUTERS
·
May 26

Editas Medicine Inc - Prices Public Offering of 55.56 Mln Shares and Warrants at $2.25 Each

THOMSON REUTERS
·
May 26